test
Frontage Announces CEO and President Promotions
Frontage Partners with Eisai and Biogen to Complete the Clarity AD study for the Alzheimer’s Drug, Lecanemab
Array
Stephen Gacheru PhD. joins Frontage as Vice President, Cell and Gene Therapy Operations
Array
James Houston joins Frontage as Vice President of Information Technology
Array
Frontage Central Labs is Awarded the Prestigious CAP Accreditation from the College of American Pathologists
Array
Jeffrey Yablon joins Frontage Laboratories as Senior Vice President
Array
Frontage Holdings Announces 2022 Interim Results
Array
Frontage Laboratories Inc. Acquires Frontage Clinical Services Inc.
Array
Frontage Holdings Announces Annual Results
Array
